| Financial Year |
March 31 2023 |
| Monetary Funds |
653,712,643.59 |
| Held-for-trading Financial Assets |
361,658,141.45 |
| Notes Receivable |
128,312,688.80 |
| Accounts Receivable |
5,886,170,796.71 |
| Advances to Suppliers |
301,507,552.14 |
| Other Receivables |
107,787,530.47 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
2,704,378.62 |
| Dividend Receivable |
-- |
| Inventories |
4,843,204.31 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
187,199,583.63 |
| Total Current Assets |
7,785,345,083.79 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
883,372,358.09 |
| Investment Properties |
-- |
| Fixed Assetes |
18,150,371,838.60 |
| Under-construction Projects |
1,334,069,520.41 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
92,528,490.73 |
| R&D expenses |
-- |
| Goodwill |
1,510,485,944.03 |
| Long-Term Deferred and Prepaid Expenses |
460,100,008.74 |
| Deferred Income Tax Assets |
357,849,123.45 |
| Other Non-Current Assets |
869,979,812.22 |
| Sub-Total of Non-Current Assets |
24,331,517,367.01 |
| Total Assets |
32,116,862,450.80 |
| Short-Term Loans |
50,184,722.21 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,221,783,180.79 |
| Accounts Payable |
247,082,637.52 |
| Accounts Received In Advance |
3,245,895.00 |
| Employee Compensation Payable |
154,689,776.60 |
| Taxes Payable |
90,208,564.09 |
| Interest Payable |
-- |
| Dividend Payable |
93,269,873.47 |
| Other payables |
2,450,106,895.48 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,219,767,452.12 |
| Other Current Liabilities |
22,603,370.43 |
| Sub-Total of Current Liabilities |
5,544,796,784.81 |
| Long-term Loans |
17,147,524,356.53 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
7,413,905.39 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
17,546,123,303.90 |
| Total Liabilities |
23,090,920,088.71 |
| Paid-In Capital(Or Share Stock) |
1,997,263,453.00 |
| Capital Surplus |
5,656,542,017.90 |
| Surplus Reserve |
97,231,643.98 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
784,464,567.30 |
| Minority Stockholder's Interest |
474,423,972.28 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
8,551,518,389.81 |
| Owner's Equity（Stockholder's Equity） |
9,025,942,362.09 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
32,116,862,450.80 |
